Most people treat acne reactively: a breakout appears, a spot treatment is applied, the pimple either resolves or doesn't. This approach addresses the endpoint of a process that started weeks earlier, which is why it produces inconsistent results. Understanding how acne actually forms — the full four-stage biological sequence from invisible microcomedone to visible inflamed lesion — changes how you approach both prevention and treatment.
The pilosebaceous unit: where acne begins
Every acne lesion originates in the pilosebaceous unit: the structure consisting of a hair follicle and its attached sebaceous gland. The sebaceous gland produces sebum, which travels up the follicle and exits through the pore opening on the skin surface. Under normal conditions, this process runs continuously and invisibly. Acne forms when this process goes wrong at one or more of four specific points.
As the Merck Manual's clinical overview of acne vulgaris explains, acne occurs through the interplay of four major factors: increased sebum production, abnormal follicular keratinisation, colonisation by Cutibacterium acnes, and activation of inflammatory responses. These factors operate in sequence, each creating the conditions for the next.
Stage 1: Excess sebum production
The process begins upstream of anything visible on the skin surface. Androgens — the hormones that spike during puberty, in the premenstrual phase, and under conditions of chronic stress — stimulate the sebaceous glands to produce more sebum than the follicle is designed to handle.
In Singapore's climate, this stage is amplified by heat. Heat directly increases metabolic activity in sebaceous glands and makes sebum more fluid, so it flows to the surface more readily. Diet adds another layer: high-glycaemic foods elevate insulin and IGF-1, which in turn amplify androgen signalling at the sebaceous gland. The excess sebum filling the follicle sets up the conditions for stage two.
Stage 2: Abnormal follicular keratinisation (the microcomedone)
The follicle wall is lined with keratinocytes that normally shed gradually, mixing with sebum and exiting through the pore. When sebum production increases, the keratinocytes lining the follicle begin to proliferate and shed abnormally — they stick together rather than shedding individually, forming a cohesive plug inside the follicle rather than exiting cleanly.
As Frontiers in Immunology's review of acne immune processes describes, hypercornification of the hair infundibulum combined with excess sebum results in the development of microcomedones. These are invisible to the naked eye — they exist beneath the skin surface as a densely packed plug of dead cells and sebum within the follicle lumen.
This is the stage that explains why topical spot treatments applied to visible pimples only address late-stage lesions. The process that produced them began weeks earlier as a microcomedone. Ingredients that normalise follicular keratinisation — retinoids and salicylic acid — work here, at stage two, preventing the microcomedone from forming rather than treating the eventual lesion it produces.
Stage 3: Bacterial colonisation
Cutibacterium acnes (formerly Propionibacterium acnes) is a commensal bacterium — it lives on healthy skin without causing problems under normal conditions. The microcomedone changes this. By filling the follicle with sebum and blocking the pore, it creates an anaerobic (oxygen-poor) environment that is ideal for C. acnes proliferation, since C. acnes is an anaerobe that thrives in the lipid-rich, oxygen-depleted conditions of a blocked follicle.
A 2026 review published in MDPI's Biomolecules journal on the evolving microbial paradigm in acne found that specific C. acnes phylotypes, particularly phylotype IA1, have high lipase activity that hydrolyses the sebum triglycerides into free fatty acids. These free fatty acids are irritating to the follicle wall, setting the stage for the inflammatory response of stage four.
In Singapore's climate, humidity and heat create conditions that encourage bacterial growth generally. Singapore's high humidity encourages C. acnes proliferation, which fuels inflammation. The tropical environment accelerates stage three, compressing the timeline from microcomedone to inflammatory lesion compared to temperate climates.
Stage 4: Inflammation and lesion formation
The final stage is the one that becomes visible. The free fatty acids produced by C. acnes lipase, combined with bacterial cell wall components, trigger an immune response in the surrounding tissue. Neutrophils migrate to the follicle. Lymphocytes follow. The follicle wall becomes inflamed, weakens, and eventually ruptures into the surrounding dermis.
As the Merck Manual describes, papules and pustules occur when C. acnes colonises closed comedones, breaking down sebum into free fatty acids that irritate the follicular epithelium and elicit an inflammatory response. When the follicle ruptures into the dermis, the comedone contents trigger a further local inflammatory reaction, producing the papule. If the inflammation is intense, a purulent pustule forms. Deeper disruption produces nodules and cysts.
This is also the stage that creates post-inflammatory hyperpigmentation (PIH). The inflammatory process — particularly in Asian skin tones with more reactive melanocytes — triggers excess melanin production in the surrounding skin, leaving the dark flat mark that persists long after the pimple has resolved. AURA Bright's hexylresorcinol and niacinamide address this post-inflammatory melanin response, targeting the dark marks that stage four inflammation produces.
Why this sequence matters for treatment
Each stage has specific intervention points. Understanding where a treatment ingredient works tells you when in the sequence it is most useful:
- Stage 1 (sebum overproduction): Niacinamide (sebum regulation), dietary glycaemic management, hormonal interventions
- Stage 2 (microcomedone formation): Retinoids (normalise follicular keratinisation), BHA/salicylic acid (dissolve the keratin-sebum plug inside the follicle)
- Stage 3 (bacterial colonisation): Benzoyl peroxide (bactericidal), azelaic acid (antimicrobial and anti-inflammatory), antibiotics (prescription)
- Stage 4 (inflammation and PIH): Anti-inflammatory ingredients (niacinamide, centella asiatica, azelaic acid), brightening actives for PIH (hexylresorcinol, niacinamide in AURA Bright)
A routine that only uses spot treatments (stage 4 intervention) misses the three earlier stages where prevention is both possible and more effective. A complete routine works across multiple stages: niacinamide for stage one, BHA for stage two, barrier-supportive ingredients to maintain the skin environment that keeps stage three from escalating, and brightening actives to manage the stage four PIH aftermath.
The non-inflammatory versus inflammatory distinction
Not every acne lesion reaches stage four. Blackheads (open comedones) and whiteheads (closed comedones) are stage two to three lesions — the follicle is blocked and the microcomedone has developed, but the inflammatory rupture has not yet occurred. These are non-inflammatory acne lesions. They are the correct target for BHA and retinoids.
Papules, pustules, nodules, and cysts are stage four inflammatory lesions where the follicle has ruptured. These require anti-inflammatory intervention alongside continued prevention of new microcomedones. Treating inflammatory lesions with BHA alone misses the inflammation component; treating only inflammation with a calming serum misses the microcomedone formation that will produce the next wave of lesions.
Acne is a four-stage process. Spot treatment addresses stage four. Clearing acne requires intervention at stages one and two, before anything is visible.
This is why consistent daily use of the right preventive ingredients produces better long-term outcomes than reactive treatment of individual pimples: the prevention is happening weeks before the lesion that would have formed actually appears.
0 nhận xét